Global Cell Banking and Storage Market Size By Type (Chamber Slides, Plates), By Application (Tissue Culture & Engineering, Gene Therapy), By Region, And Segment Forecasts, 2023 to 2032

The Global Cell Banking and Storage Market was valued at USD 10.1 billion in 2023 and is expected to surpass USD 21.4 billion by 2031, growing at a CAGR of 9.5% during the forecast period from 2023 to 2031. This market is experiencing strong growth driven by increasing biopharmaceutical R&D, rising demand for cell therapies, and advancements in cryopreservation techniques. Cell banks serve as repositories for various cell lines, stem cells, and tissues, playing a crucial role in drug development, regenerative medicine, and personalized healthcare.

As cell-based research continues to gain momentum in regenerative therapies and vaccine development, cell banking is becoming an indispensable component in both academic and industrial biotech settings. Regulatory support for stem cell applications and rising awareness around cord blood banking are also propelling the global market forward.

Drivers:

1. Growing Biopharmaceutical R&D Activities

The surge in drug discovery programs and biopharmaceutical production is increasing the need for reliable cell lines. Cell banking ensures standardized, contamination-free cell lines for consistent and reproducible research.

2. Increasing Demand for Cell Therapies

As regenerative medicine evolves, particularly in oncology and immunology, the demand for long-term storage of stem cells and genetically modified cells is rising.

3. Advancements in Cryopreservation Technology

Innovations in cryogenic storage systems, such as programmable freezers and automated liquid nitrogen tanks, have improved cell viability and safety, further enhancing the market.

Restraints:

1. High Operational and Maintenance Costs

Cell banks require sophisticated infrastructure, sterile environments, and consistent temperature control, all of which involve significant costs and regulatory compliance efforts.

2. Ethical and Regulatory Challenges

The use of embryonic stem cells and genetically modified cells remains controversial in some regions, creating regulatory hurdles and slowing market expansion.

Opportunity:

1. Rise in Cord Blood Banking Services

Increasing awareness and favorable legislation around cord blood stem cell preservation are expanding public and private banking services worldwide.

2. Emerging Markets and Personalized Medicine

Developing countries are investing heavily in biotech infrastructure. Additionally, the shift toward personalized medicine is increasing the demand for patient-specific cell storage, offering lucrative opportunities.

Market by System Type Insights:

By system type, the Master Cell Bank (MCB) segment held the dominant market share in 2023. MCBs are extensively used in manufacturing biological products due to their genetic stability and quality. The Working Cell Bank (WCB) segment is expected to witness the fastest growth as it supports continuous production in commercial-scale biomanufacturing.

Market by End-use Insights:

In terms of end use, Pharmaceutical and Biotechnology Companies accounted for the largest revenue share in 2023. These institutions rely on cell banking for consistent supply in clinical trials and drug production. Contract Research Organizations (CROs) and Academic & Research Institutions are emerging as significant end-users due to rising collaboration in gene and cell therapy research.

Market by Regional Insights:

North America led the market in 2023, driven by strong biopharma presence, supportive regulations, and high healthcare spending. Asia-Pacific is projected to grow at the fastest rate due to increasing investments in life sciences, growing awareness of stem cell preservation, and the rapid expansion of medical research facilities in China, India, and Japan.

Competitive Scenario:

Key players in the Global Cell Banking and Storage Market include:

Thermo Fisher Scientific Inc.

Merck KGaA

BioLife Solutions Inc.

Lonza Group AG

STEMCELL Technologies Inc.

Cryo-Cell International Inc.

SGS Life Sciences

Charles River Laboratories

Global Life Sciences Solutions (Cytiva)

Lifecell International Pvt. Ltd.

These companies are focusing on expanding cell banking infrastructure, enhancing cryopreservation technologies, and forging partnerships to cater to growing global demand.

Scope of Work – Global Cell Banking and Storage Market

Report Metric Details

Market Size (2023) USD 10.1 billion

Projected Market Size (2031) USD 21.4 billion

CAGR (2023-2031) 9.5%

Market Segments By System Type (MCB, WCB), By End-Use, By Region

Growth Drivers Biopharma R&D growth, demand for cell therapies, cryotech

Opportunities Cord blood banking, emerging markets, personalized medicine

Key Market Developments:

2023: Thermo Fisher Scientific expanded its cryogenic storage portfolio with a new line of automated, energy-efficient storage units tailored for cell therapy applications.

2024: Lonza Group AG announced the expansion of its global cell banking facilities in Switzerland and the U.S. to support increased demand from CDMO partners.

2025: Cryo-Cell International collaborated with a leading stem cell institute in Southeast Asia to offer integrated cord blood banking and therapy services across emerging markets.

FAQs:

1) What is the current market size of the Global Cell Banking and Storage Market?

The market was valued at USD 10.1 billion in 2023.

2) What is the major growth driver of the Global Cell Banking and Storage Market?

The rising demand for cell therapies and biopharmaceutical R&D are the major growth drivers.

3) Which is the largest region during the forecast period in the Global Cell Banking and Storage Market?

North America holds the largest market share due to its advanced infrastructure and regulatory support.

4) Which segment accounted for the largest market share in Global Cell Banking and Storage Market?

The Master Cell Bank (MCB) segment dominated the market by system type in 2023.

5) Who are the key market players in the Global Cell Banking and Storage Market?

Key players include Thermo Fisher Scientific, Merck KGaA, Lonza, BioLife Solutions, and Cryo-Cell International.